Arkolith/Insider Trading/ANRO/Form 4

Cox Christopher Nixon

DirectorAlto Neuroscience, Inc. (ANRO) · full profile →Form 4 · filed Feb 7, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 6, 2024Conversion(C)127K——716K
Feb 6, 2024Conversion(C)589K——589K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 6, 2024Conversion(C)282K—$00
Feb 6, 2024Conversion(C)1.3M—$00

Transaction Codes

C
Conversion of a derivative

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-002938) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML